The surpassing of 10,000 peer-reviewed publications citing RNAscope technology not only demonstrates the technology's robustness and reliability but also indicates a growing market adoption and awareness. This could lead to increased sales and further solidify Bio-Techne's leadership in the spatial biology market, potentially positively impacting its stock price in the short term.